Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.82
0.04 (2.25%)
At close: Aug 15, 2025, 3:59 PM
1.91
4.95%
After-hours: Aug 15, 2025, 07:55 PM EDT
Enlivex Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.33M | -15.01M | -18.93M | -22.29M | -25.99M | -29.07M | -27.16M | -26.93M | -30.05M | -31.06M | -28.61M | -26.3M | -19.49M | -14.47M | -15.6M | -14.3M | -14.23M |
Depreciation & Amortization | 447K | 545K | 709K | 762K | 814K | 835K | 856K | 834K | 798K | 777K | 706K | 671K | 617K | 546K | 496K | 411K | 349K |
Stock-Based Compensation | 1.06M | 1.15M | 1.55M | 1.58M | 1.7M | 1.95M | 2.31M | 2.37M | 2.56M | 2.71M | 3.65M | 3.56M | 3.51M | 2.91M | 1.36M | 1.19M | 728K |
Other Working Capital | -619.99K | -1.56M | -803.17K | 981.83K | -1.56M | -977.17K | -1.48M | -1.21M | -2.26M | -364K | -953K | -2.99M | -1.44M | -1.8M | -1.7M | -801K | -805K |
Other Non-Cash Items | 432.21K | 2.13M | 4.72M | 3.99M | 4.04M | 3.64M | 852K | -2.05M | -2.05M | -2.07M | -5.43M | -3.29M | -4.66M | -5.18M | -1.97M | -1.38M | -202K |
Deferred Income Tax | n/a | n/a | -112.87K | -10.87K | 223.13K | 1.62M | 1.73M | 1.63M | 4.31M | 4.89M | 1.51M | 879K | -3.24M | -5.59M | -2.21M | -1.58M | -388K |
Change in Working Capital | -733.21K | -1.23M | -895.65K | 186.35K | -1.8M | -1.84M | -1.65M | -68K | -2.03M | 804K | -928K | -2.86M | -417K | -1.36M | -1.01M | -793K | -771K |
Operating Cash Flow | -13.12M | -13.01M | -13.95M | -16.77M | -22M | -23.27M | -23.06M | -24.22M | -26.47M | -23.95M | -25.73M | -23.33M | -18.47M | -17.54M | -16.71M | -14.86M | -14.13M |
Capital Expenditures | -92K | -103K | -73.94K | -93.94K | -115.94K | -234.94K | -2.81M | -3.97M | -7.33M | -8.12M | -6.57M | -5.5M | -2.4M | -1.63M | -1.07M | -1.32M | -1.15M |
Cash Acquisitions | 303.51K | 527.51K | 272.92K | 271.65K | 352.33K | 128.33K | 68.75K | 24.78K | 1.39M | 1.39M | 1.4M | 1.45M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -33.39M | -32.33M | -27.03M | -10.6M | -3.5M | -26.2M | -30.23M | 1.03M | -30.86M | -1.6M | -15.69M | -55.56M | -36.59M | -104.42M | -94.3M | -93.65M | -87.71M |
Sales Maturities Of Investments | 38.2M | 39.18M | 34.82M | 22.73M | 13.7M | 295.07K | -11.45K | 9.99M | 8.29M | 70.84M | 80.91M | 89.99M | 119.84M | 67.63M | 57.87M | 38.78M | 10.34M |
Other Investing Acitivies | 2.12M | 1.84M | 1.86M | 97.77K | 64.18K | -20.01K | -24.44K | 15.07K | -21.16K | 70.65K | 66.63K | 35.84K | 83.26K | -36.78K | -36.43K | -54.87K | -77.37K |
Investing Cash Flow | 7.13M | 9.06M | 9.8M | 12.35M | 10.44M | -26.01M | -32.98M | 7.12M | -28.5M | 62.52M | 60.05M | 30.34M | 80.86M | -38.41M | -37.5M | -56.2M | -78.53M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3 | -3 | -3 | -3 | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 42.51K | 42.51K | 40.51K | 40.51K | n/a | n/a | n/a | 50K | 100K | 150K | 150K | 167K | 119K | 7.81M | 16.33M | 16.26M | 16.36M |
Financial Cash Flow | 6.13M | 6.45M | 5.19M | 4.94M | 559.15K | 353.15K | 353.41K | 408.98K | 416.98K | 148.98K | 147K | 164K | 116K | 60.98M | 71.51M | 71.45M | 71.54M |
Net Cash Flow | 139K | 2.49M | 800K | 276K | -11.23M | -49.15M | -55.68M | -16.69M | -54.55M | 38.72M | 34.72M | 6.97M | 62.69M | 4.62M | 16.93M | 691K | -20.27M |
Free Cash Flow | -13.25M | -13.14M | -14.02M | -16.87M | -22.11M | -23.51M | -25.87M | -28.19M | -33.8M | -32.08M | -32.3M | -28.84M | -20.88M | -19.17M | -17.78M | -16.19M | -15.28M |